IL75981A - 4-(isoxazolyl)-thiazole-2-oxamic acid derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

4-(isoxazolyl)-thiazole-2-oxamic acid derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL75981A
IL75981A IL75981A IL7598185A IL75981A IL 75981 A IL75981 A IL 75981A IL 75981 A IL75981 A IL 75981A IL 7598185 A IL7598185 A IL 7598185A IL 75981 A IL75981 A IL 75981A
Authority
IL
Israel
Prior art keywords
isoxazolyl
thiazole
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL75981A
Other languages
English (en)
Other versions
IL75981A0 (en
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of IL75981A0 publication Critical patent/IL75981A0/xx
Publication of IL75981A publication Critical patent/IL75981A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL75981A 1984-07-31 1985-07-31 4-(isoxazolyl)-thiazole-2-oxamic acid derivatives,their preparation and pharmaceutical compositions containing them IL75981A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22150/84A IT1183061B (it) 1984-07-31 1984-07-31 Composti dotati di attivita'antiallergica

Publications (2)

Publication Number Publication Date
IL75981A0 IL75981A0 (en) 1985-12-31
IL75981A true IL75981A (en) 1989-07-31

Family

ID=11192238

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75981A IL75981A (en) 1984-07-31 1985-07-31 4-(isoxazolyl)-thiazole-2-oxamic acid derivatives,their preparation and pharmaceutical compositions containing them

Country Status (13)

Country Link
US (2) US4766138A (de)
EP (2) EP0190298B1 (de)
JP (2) JPS61502959A (de)
AU (2) AU584118B2 (de)
CA (2) CA1246583A (de)
DE (2) DE3574874D1 (de)
DK (2) DK142086A (de)
ES (4) ES8608516A1 (de)
FI (2) FI85473C (de)
IL (1) IL75981A (de)
IT (1) IT1183061B (de)
WO (2) WO1986000900A1 (de)
ZA (1) ZA855743B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1183061B (it) * 1984-07-31 1987-10-05 Zambon Spa Composti dotati di attivita'antiallergica
IT1204960B (it) * 1987-03-25 1989-03-10 Zambon Farmaceutici Spa Composti dotati di attivita' antiallergica
US4946963A (en) * 1987-11-13 1990-08-07 The University Of North Carolina At Chapel Hill Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones
DE3844227A1 (de) * 1988-12-29 1990-07-05 Basf Ag 3(2h)-pyridazinonderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
DE19638667C2 (de) 1996-09-20 2001-05-17 Osram Opto Semiconductors Gmbh Mischfarbiges Licht abstrahlendes Halbleiterbauelement mit Lumineszenzkonversionselement
CN1534802B (zh) 1996-06-26 2010-05-26 奥斯兰姆奥普托半导体股份有限两合公司 具有发光变换元件的发光半导体器件
DE19625622A1 (de) * 1996-06-26 1998-01-02 Siemens Ag Lichtabstrahlendes Halbleiterbauelement mit Lumineszenzkonversionselement
EP3002283B1 (de) * 2003-12-26 2017-06-14 Kyowa Hakko Kirin Co., Ltd. Thiazol-derivate
EP1988077A4 (de) 2006-02-23 2009-09-02 Shionogi & Co Nitrogene heterocyclische derivate, die mit cyclischen gruppen substituiert sind

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2429210A1 (fr) * 1978-06-19 1980-01-18 Fabre Sa Pierre Derives de phenyl-4 thiazolyl-2 oxamates utiles dans le traitement de l'asthme
DE3027527A1 (de) * 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Neue oxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
FR2494272A1 (fr) * 1980-11-19 1982-05-21 Fabre Sa Pierre Derives de l'acide thiazolyl-2 oxamique substitues en position 4 par un radical thienyle ou furyle, leur preparation et leur utilisation comme medicaments
IT1183061B (it) * 1984-07-31 1987-10-05 Zambon Spa Composti dotati di attivita'antiallergica

Also Published As

Publication number Publication date
ES8703459A1 (es) 1987-02-16
FI83650C (fi) 1991-08-12
EP0190298A1 (de) 1986-08-13
FI83650B (fi) 1991-04-30
CA1246583A (en) 1988-12-13
ES552513A0 (es) 1987-10-16
DK141986D0 (da) 1986-03-26
AU584118B2 (en) 1989-05-18
FI85473B (fi) 1992-01-15
DK141986A (da) 1986-05-28
ES8705434A1 (es) 1987-05-01
ZA855743B (en) 1986-05-28
AU4724885A (en) 1986-02-25
ES546420A0 (es) 1986-07-16
FI861329A (fi) 1986-03-26
DE3573781D1 (en) 1989-11-23
EP0191045A1 (de) 1986-08-20
DK142086D0 (da) 1986-03-26
US4766137A (en) 1988-08-23
AU583847B2 (en) 1989-05-11
EP0190298B1 (de) 1989-10-18
ES8800217A1 (es) 1987-10-16
ES8608516A1 (es) 1986-07-16
IT8422150A0 (it) 1984-07-31
WO1986000899A1 (en) 1986-02-13
DK164364C (da) 1992-11-02
WO1986000900A1 (en) 1986-02-13
FI861330A0 (fi) 1986-03-26
DE3574874D1 (de) 1990-01-25
JPH0576946B2 (de) 1993-10-25
CA1261847C (de) 1989-09-26
FI861329A0 (fi) 1986-03-26
EP0191045B1 (de) 1989-12-20
ES546419A0 (es) 1987-02-16
US4766138A (en) 1988-08-23
JPS61502959A (ja) 1986-12-18
IT1183061B (it) 1987-10-05
ES552514A0 (es) 1987-05-01
CA1243318A (en) 1988-10-18
JPH0574592B2 (de) 1993-10-18
IL75981A0 (en) 1985-12-31
FI861330A (fi) 1986-03-26
JPS61502896A (ja) 1986-12-11
DK164364B (da) 1992-06-15
DK142086A (da) 1986-05-29
FI85473C (fi) 1992-04-27
AU4671785A (en) 1986-02-25

Similar Documents

Publication Publication Date Title
IL76453A (en) Isoxazolecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL78970A (en) 3-(heteroaralkylamino-alkyl)-3-benzazepin-2-one derivatives,their preparation and pharmaceutical compositions containing them
IL79309A0 (en) (heterocyclic substituted-phenoxy)alkyl-isoxazoles and-furans,their preparation and pharmaceutical compositions containing them
IL76405A0 (en) 1,3-diacyl-2-oxyindole derivatives,their preparation and pharmaceutical compositions containing them
IL76675A0 (en) Piperidine derivatives,their preparation and pharmaceutical compositions containing them
IL78942A0 (en) Thiazolidinecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL74826A0 (en) 3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL81179A0 (en) Azine acid derivatives,their preparation and pharmaceutical compositions containing them
IL83049A (en) 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL84808A0 (en) Furanuronic acid derivatives,their preparation and pharmaceutical compositions containing them
IL75981A (en) 4-(isoxazolyl)-thiazole-2-oxamic acid derivatives,their preparation and pharmaceutical compositions containing them
IL75603A0 (en) 1,3-dioxanylheptenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL76312A (en) Xenocoumacins and derivatives thereof,their preparation and pharmaceutical compositions containing them
EP0159652A3 (en) 4-phenylphthalazine derivatives, their preparation and pharmaceutical compositions containing them
IL75913A0 (en) Phenyl-nonatetraenoic acid derivatives,their preparation and pharmaceutical compositions containing them
DE3569526D1 (en) Glutarimide derivatives, their preparation and pharmaceutical compositions containing them
IL75775A0 (en) Aminoeburnanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL75776A (en) Nitroapovincaminic acid derivatives,their preparation and pharmaceutical compositions containing them
IL72079A (en) 4-benzoyl-5-hydroxy-1-benzocyclobutenecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL68520A0 (en) 5-oxo-2-pyrrolidinepropanoic acid and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL74616A0 (en) Substituted isochromanes and benzoxepines,and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
ZA857911B (en) Piperidine derivatives,their preparation and pharmaceutical compositions containing them
IL76282A0 (en) Amino acid derivatives,their preparation and pharmaceutical compositions containing them
DE3570667D1 (en) 3-aminopropyloxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL74776A (en) 14-hydroxyimino eburnane derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void